Add this topic to your myFT Digest for news straight to your inbox
IP Group’s “increased value” bid is actually a 2 per cent discount to net assets
John Varley faces prosecution not for bringing down a bank — but trying to save one
Neither group has quite scored as investors have hoped
Merger would create a £1.3bn leader in intellectual property commercialisation
No laughing matter for minority investors
Fund managers Neil Woodford and Mark Barnett are heavily invested in the IP company
Investing in intellectual property commercialisation is not without risks
With its new name, Imperial Innovations is trying to put a tough year behind it
Shares in British biotech group fall by more than two-thirds
Star fund manager takes 21% share in technology-focused investment company
Venture capitalists invest in London university’s technology fund to cash in on research
PureTech Health’s float comes as momentum grows in UK’s life science investment
Latest directors’ deals at AstraZeneca, Imperial Innovations and Real Good Food Company
Investment company closes in on one of Europe’s biggest biotech flotations
You can find good assets relatively cheaply by looking in the labs at the world’s top universities
Investors need patience as well as tolerance of risks
Aim-traded companies have seen material investments
Profits slide 7% on profit-taking
International Edition